Yes Bank must reinstate Rs 8,415 crore in AT1 bonds following a Supreme Court order, causing its CET1 capital ratio to drop by 240 basis points to 11.4%. This accounting change creates uncertainty regarding the bank's future capital needs, leading to a 17% decline in the stock price as investors assess the impact on its lending capacity and potential for equity dilution.
Yes Bank is navigating a significant change in its financial structure following a Supreme Court ruling that mandates the reinstatement of Rs 8,415 crore in Additional Tier 1 (AT1) bonds. These bonds were previously written down in 2020 during the bank's restructuring phase. The court order requires the bank to move this amount from its reserves back to its liabilities, an adjustment that will lower its Common Equity Tier 1 (CET1) ratio by roughly 240 basis points to 11.4%.
This reduction in the capital adequacy ratio is important for investors because banks are required by regulators to maintain a minimum buffer of capital to cover risks and support loan growth. While the bank’s total Tier 1 capital ratio is expected to stay near 13.7%—still above regulatory requirements—the shrinking buffer leaves less room for aggressive lending expansion without bringing in new capital.
The stock market has reacted to this uncertainty, with Yes Bank shares falling 17% following the verdict. The decline reflects investor concerns that the bank might need to raise fresh equity to replenish its capital buffers, which could dilute the value for existing shareholders.
Management has clarified that this is primarily an accounting change for now and there is no immediate cash outflow required to repay the bondholders. However, the exact timeline and structure for future coupon payments on these reinstated bonds are still being evaluated. The bank's leadership is currently assessing potential capital-raising plans to ensure that the institution can maintain its growth targets, which were highlighted by a 23.7% year-on-year rise in advances in the September quarter.
For investors, the key monitorable will be the management’s strategy for strengthening the balance sheet. With Japan’s Sumitomo Mitsui Banking Corp holding a 24.9% stake, the bank’s path forward regarding capital infusion or dilution will be crucial. Future updates on how the bank plans to balance its growth strategy with the need to maintain healthy regulatory capital buffers will likely be the primary focus in the coming quarters.